Not logged in Share Save
Efficacy of up to 4 years of tralokinumab in adults with moderate-to-severe atopic dermatitis Gooderham, Melinda; Ameen, Mahreen; Hong, H. Chih-ho; Katoh, Norito; Langley, Richard G.; Peris, Ketty; Reich, Kristian; Silvestre, Juan F.; Simpson, Eric; Werfel, Thomas; Gjerum, Le; Tindberg, Ann-marie; Oland, Christian Bjerregard; Blauvelt, Andrew Share Save
Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of eight clinical trials Reich, Kristian; Langley, Richard G.; Silvestre Salvador, Juan Francisco; Staumont-Salle, Delphine; Costanzo, Antonio; Pink, Andrew E.; Paller, Amy S.; Katoh, Norito; Wollenberg, Andreas; Warren, Richard B.; Blauvelt, Andrew; Bjerregard Oland, Christian; Tindberg, Ann-Marie; Gjerum, Le; Simpson, Eric L. Share Save
Share Save
Effects of a Gel Containing the Defined Microalgae Extract Spiralin® on the Skin Microbiome and Clinical Activity in Atopic Dermatitis: A Double-Blind, Intraindividual Vehicle-Controlled Proof-Of-Concept Study Reich, Kristian; Trettel, Natalie; Reich, Jeremias L. K.; Sorbe, Christina; Bickert, Thomas; Hartmann, Jan; Harder, Inken; Gerdes, Sascha; Weidinger, Stephan Share Save
Share Save
Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis Eyerich, Kilian; Asadullah, Khusru; Pinter, Andreas; Weisenseel, Peter; Reich, Kristian; Paul, Carle; Sabat, Robert; Wolk, Kerstin; Eyerich, Stefanie; Lauffer, Felix; Angsana, Julianty; Taut, Friedemann J. H.; Kohler, Kristen; Chen, Yanqing; Sendecki, Jocelyn; Leung, Monica W. L.; Wegner, Sven; Personke, Yvonne; Gomez, Mario; Krueger, Nenja; Tabori, Sarah; Schaekel, Knut Share Save
Stability of long-term therapeutic responses to tralokinumab in adults with moderate-to-severe atopic dermatitis Blauvelt, Andrew; Hong, H. Chih-ho; Peris, Ketty; Katoh, Norito; Tauber, Marie; Ameen, Mahreen; Gooderham, Melinda; Oland, Christian Bjerregard; Tindberg, Ann-Marie; Gjerum, Le; Reich, Kristian Share Save
Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials Reich, Kristian; Langley, Richard G.; Silvestre, Juan Francisco; Staumont-Salle, Delphine; Costanzo, Antonio; Pink, Andrew; Paller, Amy; Katoh, Norito; Wollenberg, Andreas; Warren, Richard B.; Oland, Christian Bjerregard; Tindberg, Ann-Marie; Gjerum, Le; Simpson, Eric Share Save
SARS-CoV-2-Infektionen bei Patienten mit Psoriasis in Deutschland: Daten aus den deutschen Registern PsoBest und CoronaBest Lopez, Maria Jose Valencia; Meineke, Anna; Stephan, Brigitte; Rustenbach, Stephan Jeff; Kis, Anne; Thaci, Diamant; Mrowietz, Ulrich; Reich, Kristian; Staubach-Renz, Petra; von Kiedrowski, Ralph; Bogena, Henriette; Augustin, Matthias Share Save
SARS-CoV-2 infection among psoriasis patients in Germany: Data from the German registries PsoBest and CoronaBest Lopez, Maria Jose Valencia; Meineke, Anna; Stephan, Brigitte; Rustenbach, Stephan Jeff; Kis, Anne; Thaci, Diamant; Mrowietz, Ulrich; Reich, Kristian; Staubach-Renz, Petra; von Kiedrowski, Ralph; Bogena, Henriette; Augustin, Matthias Share Save
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries Lopez, Maria Jose Valencia; Stephan, Brigitte; Meineke, Anna; Wolf, Sandra; Thaci, Diamant; Mrowietz, Ulrich; Andrees, Valerie; Rustenbach, Stephan Jeff; Reich, Kristian; Thalmann, Linus; Bogena, Henriette; Staubach, Petra; von Kiedrowski, Ralph Michael; Augustin, Matthias Share Save
Targeting IL-13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years Guttman-Yassky, Emma; Kabashima, Kenji; Staumont-Salle, Delphine; Nahm, Walter K.; Pauser, Sylvia; Da Rosa, Joel Correa; Martel, Britta Cathrina; Madsen, Daniel Elenius; Ropke, Mads; Arlert, Petra; Steffensen, Louise; Blauvelt, Andrew; Reich, Kristian Share Save
Safety of tralokinumab for the treatment of atopic dermatitis in patients with up to 4.5 years of treatment: an updated integrated analysis of eight clinical trials Reich, Kristian; Langley, Richard G.; Silvestre, Juan Francisco; Staumont-Salle, Delphine; Costanzo, Antonio; Pink, Andrew; Paller, Amy; Katoh, Norito; Wollenberg, Andreas; Warren, Richard B.; Oland, Christian Bjerregard; Tindberg, Ann-Marie; Gjerum, Le; Simpson, Eric Share Save
Continuous tralokinumab treatment over 4 years in adults with moderate-to-severe atopic dermatitis provides long-term disease control Blauvelt, Andrew; Langley, Richard G.; Peris, Ketty; Silvestre, Juan Francisco; Katoh, Norito; Tauber, Marie; Pinter, Andreas; Ameen, Mahreen; Gooderham, Melinda; Oland, Christian Bjerregard; Tindberg, Ann-Marie; Gjerum, Le; Reich, Kristian Share Save
Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA) Reich, Kristian; Bianchi, Luca; Khemis, Abdallah; Maul, Julia-Tatjana; Tsianakas, Athanasios; Schempp, Christoph M.; Petersen, Kim; Noergaard, Mia M.; Puig, Lluis Share Save
Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study Guttman-Yassky, Emma; Simpson, Eric L.; Reich, Kristian; Kabashima, Kenji; Igawa, Ken; Suzuki, Tetsuya; Mano, Hirotaka; Matsui, Takeshi; Esfandiari, Ehsanollah; Furue, Masutaka Share Save
Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis - Authors' reply Guttman-Yassky, Emma; Simpson, Eric L.; Reich, Kristian; Kabashima, Kenji; Igawa, Ken; Suzuki, Tetsuya; Mano, Hirotaka; Matsui, Takeshi; Esfandiari, Ehsanollah; Furue, Masutaka Share Save
Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
